These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6092501)

  • 1. Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity.
    Maury CP; Junge W; Teppo AM
    J Lab Clin Med; 1984 Nov; 104(5):761-6. PubMed ID: 6092501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis.
    Wegelius O; Teppo AM; Maury CP
    Br Med J (Clin Res Ed); 1982 Feb; 284(6316):617-9. PubMed ID: 6802258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidosis and rheumatoid arthritis.
    Husby G
    Clin Exp Rheumatol; 1985; 3(2):173-80. PubMed ID: 3893817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute phase response and its relation to amyloid A degrading activity in serum of patients with rheumatoid arthritis undergoing arthroplasty.
    Maury CP; Teppo AM; Raunio P
    Eur J Clin Invest; 1983 Feb; 13(1):73-8. PubMed ID: 6191991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.
    Hol PR; van Ederen AM; Snel FW; Langeveld JP; Veerkamp JH; Gruys E
    Br J Exp Pathol; 1985 Jun; 66(3):279-92. PubMed ID: 2860918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP; Wegelius O
    Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 1-Antitrypsin and reactive systemic amyloidosis.
    Maury CP; Teppo AM; Fröseth B; Wegelius O
    Clin Sci (Lond); 1983 Apr; 64(4):453-4. PubMed ID: 6600668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A noninvasive screening of systemic reactive (secondary) AA amyloidosis, based on reduced amyloid degrading activity of amyloidotic serum.
    Ravid M; Greenman Y; Shapira J; Kedar I
    Isr J Med Sci; 1990 Apr; 26(4):191-4. PubMed ID: 2347684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis.
    Maury CP; Teppo AM
    Lancet; 1982 Jul; 2(8292):234-7. PubMed ID: 6124670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of esterases in plasma from Ghanaian and British subjects.
    Williams FM; Nicholson EN; Woolhouse NW; Adjepon-Yamoah KK; Rawlins MD
    Eur J Clin Pharmacol; 1986; 31(4):485-9. PubMed ID: 3028817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual variations in enzymes controlling organophosphate toxicity in man.
    Mutch E; Blain PG; Williams FM
    Hum Exp Toxicol; 1992 Mar; 11(2):109-16. PubMed ID: 1349216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid A fibril degrading activity in serum in liver disease--relation to serum acute phase and other protein levels.
    Maury CP; Teppo AM; Salaspuro MP
    Clin Chim Acta; 1983 Jun; 131(1-2):29-37. PubMed ID: 6883707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid 'degrading factor activity': a non-specific calcium-mediated effect.
    Scott DL; Bracken P; Bacon PA; Husby G
    Clin Sci (Lond); 1985 Mar; 68(3):333-9. PubMed ID: 3918827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloidosis in rheumatoid arthritis.
    Husby G
    Ann Clin Res; 1975 Jun; 7(3):154-67. PubMed ID: 1103711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amyloidosis in patients with rheumatoid arthritis].
    Bluszcz-Roznowska A; Kucharz EJ
    Przegl Lek; 2005; 62(12):1532-7. PubMed ID: 16786790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils.
    Caspi D; Baltz ML; Feinstein A; Munn EA; Pepys MB
    Clin Exp Immunol; 1984 Sep; 57(3):647-56. PubMed ID: 6467683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
    Koc A; Cengiz M; Ozdemir ZC; Celik H
    Pediatr Hematol Oncol; 2012 May; 29(4):345-53. PubMed ID: 22568797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised circulating interleukin-18 levels in reactive AA-amyloidosis.
    Maury CP; Tiitinen S; Laiho K; Kaarela K; Liljeström M
    Amyloid; 2002 Jun; 9(2):141-4. PubMed ID: 12440487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs of cross-seeding: aortic medin amyloid as a trigger for protein AA deposition.
    Larsson A; Malmström S; Westermark P
    Amyloid; 2011 Dec; 18(4):229-34. PubMed ID: 22070546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.